Wockhardt picks Aurangabad (The Telegraph)
Mumbai, Sept. 18 : Wockhardt Ltd is joining hands with Maharashtra Industrial Development Corporation (MIDC) to set up a special economic zone (SEZ) in Aurangabad. Around Rs 700 crore will be invested over the next four years to set up the SEZ.

FDA Approves Center Expansion Of Cardiovascular Systems, Inc. Clinical Trial Of The Orbital Atherectomy System (Medical News Today)
Cardiovascular Systems, Inc. (CSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the expansion of the OASIS clinical trial from ten to 20 centers. The OASIS trial, sponsored by CSI, is being conducted to gather safety and effectiveness data on the Orbital Atherectomy System (OAS). [click link for full article]

St. Jude Medical Announces FDA and European CE Mark Approvals of Tendril ST(R) Pacemaker Lead (Business Wire via Yahoo! Finance)
ST. PAUL, Minn.----Sept. 19, 2006--St. Jude Medical, Inc. today announced U.S. Food and Drug Administration and European CE Mark approvals of the new Tendril ST model 1788 lead, a new pacemaker lead whose thin structure is designed for easier implantation.